Clinical Trial Update: Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating infusion of donor-derived natural killer cells after donor stem cell transplant for various advanced cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Leukemia
• Lymphoma
• Lymphoproliferative Disorder
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Disorders

Drugs mentioned

• Donor natural killer cells

Snippet

Sponsor: Asan Medical Center | Conditions: Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders | Phase 1, Phase 2 | Status: COMPLETED